These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 12552972

  • 1. Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma.
    Berglund A, Edler D, Molin D, Nordlinder H, Graf W, Glimelius B.
    Anticancer Res; 2002; 22(6B):3653-9. PubMed ID: 12552972
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients.
    Paradiso A, Simone G, Petroni S, Leone B, Vallejo C, Lacava J, Romero A, Machiavelli M, De Lena M, Allegra CJ, Johnston PG.
    Br J Cancer; 2000 Feb; 82(3):560-7. PubMed ID: 10682666
    [Abstract] [Full Text] [Related]

  • 4. Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil.
    Aschele C, Debernardis D, Tunesi G, Maley F, Sobrero A.
    Clin Cancer Res; 2000 Dec; 6(12):4797-802. PubMed ID: 11156237
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH, Kwon HC, Oh SY, Lee DM, Lee S, Lee JH, Roh MS, Kim DC, Park KJ, Choi HJ, Kim HJ.
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [Abstract] [Full Text] [Related]

  • 6. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer.
    Edler D, Hallström M, Johnston PG, Magnusson I, Ragnhammar P, Blomgren H.
    Clin Cancer Res; 2000 Apr; 6(4):1378-84. PubMed ID: 10778966
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
    Kamoshida S, Matsuoka H, Ishikawa T, Maeda K, Shimomura R, Inada K, Tsutsumi Y.
    Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
    Ishida H, Yamada H, Shirakawa K, Nakada H, Ohsawa T, Takeuchi I, Okada N, Yokoyama M, Inokuma S, Suzuki T, Odaka A, Hoshino T, Murata N, Hashimoto D, Itoyama S, Mori T, Matsumoto Y, Miura T.
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1621-6. PubMed ID: 14619479
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.
    Shiga H, Heath EI, Rasmussen AA, Trock B, Johnston PG, Forastiere AA, Langmacher M, Baylor A, Lee M, Cullen KJ.
    Clin Cancer Res; 1999 Dec; 5(12):4097-104. PubMed ID: 10632346
    [Abstract] [Full Text] [Related]

  • 12. Increased thymidylate synthase gene expression in liver metastases from colorectal carcinoma: implications for chemotherapeutic options and survival.
    Bathe OF, Franceschi D, Livingstone AS, Moffat FL, Tian E, Ardalan B.
    Cancer J Sci Am; 1999 Dec; 5(1):34-40. PubMed ID: 10188059
    [Abstract] [Full Text] [Related]

  • 13. Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy.
    Aschele C, Debernardis D, Lonardi S, Bandelloni R, Casazza S, Monfardini S, Gallo L.
    J Clin Oncol; 2004 Sep 15; 22(18):3758-65. PubMed ID: 15365072
    [Abstract] [Full Text] [Related]

  • 14. Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma.
    Wong NA, Brett L, Stewart M, Leitch A, Longley DB, Dunlop MG, Johnston PG, Lessells AM, Jodrell DI.
    Br J Cancer; 2001 Dec 14; 85(12):1937-43. PubMed ID: 11747337
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
    Edler D, Kressner U, Ragnhammar P, Johnston PG, Magnusson I, Glimelius B, Påhlman L, Lindmark G, Blomgren H.
    Clin Cancer Res; 2000 Feb 14; 6(2):488-92. PubMed ID: 10690528
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H, Iinuma H, Watanabe T.
    Oncol Rep; 2008 Mar 14; 19(3):729-35. PubMed ID: 18288408
    [Abstract] [Full Text] [Related]

  • 17. Recurrence and 5-FU sensitivity of stage III/Dukes' C colorectal cancer with occult neoplastic cells in lymph node sinuses.
    Mukai M, Sato S, Ninomiya H, Wakui K, Komatsu N, Tsuchiya K, Nakasaki H, Makuuchi H.
    Oncol Rep; 2005 Nov 14; 14(5):1165-9. PubMed ID: 16211280
    [Abstract] [Full Text] [Related]

  • 18. Expression of thymidylate synthase in liver and lung metastases of colorectal cancer and their matched primary tumours.
    Ohrling K, Edler D, Hallström M, Ragnhammar P.
    Anticancer Res; 2008 Nov 14; 28(3B):1741-7. PubMed ID: 18630453
    [Abstract] [Full Text] [Related]

  • 19. Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil.
    Cascinu S, Aschele C, Barni S, Debernardis D, Baldo C, Tunesi G, Catalano V, Staccioli MP, Brenna A, Muretto P, Catalano G.
    Clin Cancer Res; 1999 Aug 14; 5(8):1996-9. PubMed ID: 10473077
    [Abstract] [Full Text] [Related]

  • 20. Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin.
    Ichikawa W, Ooyama A, Toda E, Sugimoto Y, Oka T, Takahashi T, Shimizu M, Sasaki Y, Hirayama R.
    Cancer Chemother Pharmacol; 2006 Dec 14; 58(6):794-801. PubMed ID: 16528528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.